We were pleased to host the Clinical Trials Transformation Initiative (CTTI) through a MDICx Series presentation. This session, moderated by MDIC President & CEO, Bill Murray, describes the work CTTI has been doing to advance the use of central IRBs for multi-center clinical trials. Featured speakers included: Cynthia Hahn, Chief Operating Officer, The Feinstein Institute for Medical Research and Soo Bang, Sr. Director, Global Alliances & Business Development, Celgene Corporation